Apollo Funds Help Bayer Raise €3bn for LARC Non-Control Entity
Bayer raised €3 billion in equity from funds managed by Apollo to finance its long-acting reversible contraceptives (LARC) business. Apollo funds and affiliates are expected to hold a minority, non-controlling interest in a new entity, while Bayer keeps majority stake and full operational control. Bayer says the move supports balance-sheet strength and liquidity needs.